Search

This is Hala Ali, a postdoctoral researcher at Bacteriology Department, Animal Health Research Institute, Egypt. I am looking for sponsor lab to host me for 6 or 9 months as a postdoc scholar funded by Egypt. I am interested in developing n

Adaptive Phage Therapeutics will be collaborating with Oyster Point Pharma (Nasdaq: OYST) to develop therapies to target multiple opthalmic diseases using APT’s PhageBank™ technology.

Adaptive Phage Therapeutics dosed the first patient in their phase 1/2 study to evaluate their PhageBank™ technology as a treatment for UTIs.

Michael Tisza and Christopher Buck (National Cancer Institute, NIH) published a new paper in PNAS showing how a catalog of > 45,000 viruses associated with human bodies reveals hidden associations with chronic diseases. Specifically, they f

Saartje Uyttebroek (UZ Leuven & KU Leuven) and colleagues published a new review in Antibiotics showing the potential role of phages in the treatment of recalcitrant chronic rhinosinusitis. They also discuss considerations for implementing

Tridib Mahata (Tel Aviv University) and colleagues published a new paper in PNAS showing a new phage mechanism for selective nicking of dUMP-containing DNA.

## Evergreen is coming and we are all-in! Sign up here to be part of the longest running phage meeting. Phagebiotics Research Foundation and Phage Directory present the 24th biennial Evergreen International Phage Meeting August 2-5th 2021

Dear current & future members of ISVM (International Society for Viruses of Microorganisms) Please take 4 min to fill out this survey to keep your membership active or to join our society. Stay up-to-date with exciting events that await th

My advisor is looking for a student who’s interested in phage biology to study with him for Master’s degree at University of Florida, college of veterinary medicine. He has tuition fee and expenses for the student. If anyone knows a undergr

A study led by Carlos Gonzalez and colleagues at the Center for Phage Technology at Texas A&M has led to the development of the first curative and preventive phage treatment against Xylella fastidiosa, which causes Pierce’s disease in grape

Valuable phages have good shelf-life properties, but how can we reliably characterize the structural parts of the phage particle? Tze Thung (Centre to Impact AMR, Monash University) and colleagues published a new mSystems paper on their new

Branko Rihtman (University of Warwick) and colleagues have published a new paper in Current Biology on their identification of an unusual nucleotide substitution from deoxythymidine to deoxyuridine in a novel family of phages belonging to N

Medeea Popescu (Stanford University) and colleagues published a new review in Annual Review of Virology covering what is currently known about phages and the immune system.

Recognition for the importance of studying phages is growing! Frontiers in Microbiology has introduced a new Phage Biology section!

Some of you may recall that, last year, I put out a call to contribute to a special issue of Pharmaceuticals on “Bacteriophages as Therapeutic Delivery Vehicles.” We have 10 articles published or near completion already but there’s room fo

PHAVES #18 will be a seminar by Rob McBride, co-founder of Felix Biotechnology, on Tues, June 8, 5PM Pacific time. Rob will give a talk on 'Using machine learning to design phages with enhanced therapeutic features'. Small group networking

The African Phage Forum (APF) hosted its third and fourth events in April and May — thanks to all those who attended! APF 3: Dr. Jesca Nakavuma, Veterinarian, Senior Lecturer, Microbiologist, and Former Deputy Principal of the College of V

PHAVES #18 will be a seminar by Rob McBride, co-founder of Felix Biotechnology, on Tues, June 8, 5PM Pacific time. Rob will give a talk on 'Using machine learning to design phages with enhanced therapeutic features'. Small group networking

The Australian Society for Microbiology annual conference is approaching fast — next week to be exact! (May 31-June 3). Excitingly, the program features lots of phage talks! This is a hybrid event, and will run both in-person and online. Re

PhageSuisse will host its third webinar on June 1st at 19h00, entitled "phageSuisse meets industry" with Dr. Frenk Smrekar from JAFRAL and Dr. Lorenzo Corsini from PhagoMed.